ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Comparison of Induction and Maintenance Immunosuppression Regimens in Intestinal and Multivisceral Transplantation: An Analysis of the UNOS Registry

S. Nagai,1 M. Rizzari,1 Y. Muszkat,2 K. Collins,1 A. Yoshida,1 S-.M. Jafri,2 M. Abouljoud.1

1Transplant and Hepatobiliary Surgery, Henry Ford Hospital, Detroit, MI
2Gastroenterology, Henry Ford Hospital, Detroit, MI.

Meeting: 2018 American Transplant Congress

Abstract number: 88

Keywords: Antilymphocyte antibodies, Graft survival, Rejection, Sirolimus (SLR)

Session Information

Session Name: Concurrent Session: Small Bowel: All Topics

Session Type: Concurrent Session

Date: Sunday, June 3, 2018

Session Time: 2:30pm-4:00pm

 Presentation Time: 3:42pm-3:54pm

Location: Room 210

Aim: Induction and maintenance immunosuppression regimens in intestinal transplant widely vary among centers. The aim of this study was to investigate an association between immunosuppression regimens and transplant outcomes.

Methods: We examined adult and pediatric patients who underwent primary intestinal/multivisceral transplant between January 1, 2001 and March 31, 2017 by using the United Network Organ Sharing registry. Intestine transplant without liver graft group and intestine and liver transplant group were separately analyzed. Patients were categorized based on immunosuppression regimens. Induction regimen groups included none, anti-thymocyte globulin (ATG) with or without rituximab, basiliximab, and alemtuzumab. Additional maintenance agent groups included none, mycophenolic acid, and sirolimus/everlolimus (mTOR-i). Graft and patient survival, death associated with infection, and incidence of acute rejection were evaluated using Cox and logistic multivariable analyses. Risks were adjusted for recipient age/ethnicity/functional status, donor age, and ischemia time.

Results: A total of 1676 patients were eligible for this study (intestine without liver [n=780], intestine with liver [n=896]). In the intestine without liver group, alemtuzumab (hazard ratio [HR]=0.56, P=0.012) and mTOR-i (HR=0.62, P=0.026) showed significantly better graft survival, compared with ATG+rituximab and no additional maintenance agent, respectively. In the intestine with liver group, there was no induction regimen superior to others regarding graft/patient survival, whereas a risk of death associated with infection was lowest in the ATG+rituximab group and highest in the alemtuzumab group (HR=3.324, P=0.034). The mTOR-i group showed significantly better graft outcome in intestine and liver transplant (HR=0.476, P=0.003 [Ref. no additional maintenance agent]). A risk of acute rejection was significantly lower in the ATG+rituximab group, compared with the groups of ATG alone or almtuzumab, regardless of a graft type.

Conclusion: Our results suggested that alemtuzumab induction with mTOR-i as an additional maintenance agent seemed appropriate in intestinal transplant without liver graft, and that ATG+rituximab induction with mTOR-i may be a better option in intestinal transplant with liver graft.

CITATION INFORMATION: Nagai S., Rizzari M., Muszkat Y., Collins K., Yoshida A., Jafri S-.M., Abouljoud M. Comparison of Induction and Maintenance Immunosuppression Regimens in Intestinal and Multivisceral Transplantation: An Analysis of the UNOS Registry Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Nagai S, Rizzari M, Muszkat Y, Collins K, Yoshida A, Jafri S-M, Abouljoud M. Comparison of Induction and Maintenance Immunosuppression Regimens in Intestinal and Multivisceral Transplantation: An Analysis of the UNOS Registry [abstract]. https://atcmeetingabstracts.com/abstract/comparison-of-induction-and-maintenance-immunosuppression-regimens-in-intestinal-and-multivisceral-transplantation-an-analysis-of-the-unos-registry/. Accessed May 9, 2025.

« Back to 2018 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences